Prostate cancer is the second leading cause of cancer death in men. The cancer stems from a malignant tumor that originates in the prostate gland. As the tumor grows it can spread […]
[Video Profile] Interview with Dr. Randal Chase, CEO of ImmunoVaccine Technologies
ImmunoVaccine Technologies (IVT) is a private biotechnology company developing therapeutic cancer and infectious disease vaccines. VacciMax technology is based on a novel approach to the use of liposomes. While liposomes typically contribute […]
[Video Profile] Interview with Craig Davenport, President & CEO of Endocare
Each year over 234,000 new cases of prostate cancer are diagnosed in the U.S. Treatment options include surgery, radiation therapy, hormone therapy, “watchful waiting” and cryotherapy. Treatment depends on factors including the […]
[Video Profile] Interview with Ron Andrews, President & CEO of Clarient
Clarient provides access to technologies and services for the characterization, assessment and treatment of cancer. The company offers a full range of diagnostic technologies and services for the clinical cancer diagnostics industry […]
Rockland Technimed: Tissue Viability Imaging
Early detection of ischemic injury, though difficult to achieve, is becoming increasingly critical to the proper utilization of new interventional procedures. Experts note that although Magnetic Resonance Angiography can evaluate vessel anatomy […]
